Almila Erol1,2, Stacey J Winham3, Susan L McElroy4,5, Mark A Frye1, Miguel L Prieto6, Alfredo B Cuellar-Barboza7, Manuel Fuentes8, Jennifer Geske3, Nicole Mori4, Joanna M Biernacka1,3, William V Bobo1. 1. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. 2. Department of Psychiatry, Ataturk Education and Research Hospital, Izmir, Turkey. 3. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. 4. Lindner Center of HOPE, Mason, OH, USA. 5. University of Cincinnati, Cincinnati, OH, USA. 6. Departamento de Psiquiatría, Facultad de Medicina, Universidad de los Andes, Santiago, Chile. 7. Department of Psychiatry, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico. 8. Department of Psychiatry, Universite Desarrollo and Clinica Allemana, Santiago, Chile.
Abstract
OBJECTIVES: To examine the independent effects of sex on the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I disorder (BP-I) or bipolar II disorder (BP-II). METHODS: We analyzed data from the first 1,225 patients enrolled in the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder. Demographic and clinical variables were ascertained using standardized questionnaires; height and weight were assessed to determine body mass index (BMI). Rates of rapid cycling, cycle acceleration, and increased severity of mood episodes over time were compared between women and men overall and within subgroups defined by bipolar disorder subtype (BP-I or BP-II). Multiple logistic regression analysis was used to assess the independent effect of sex on the risk of these indicators of adverse illness course. RESULTS: Women had significantly higher rates of rapid cycling than men. Overall rates of rapid cycling were higher in patients with BP-II than BP-I; and sex differences in the rate of rapid cycling were more pronounced in patients with BP-II than BP-I, although the power to detect statistically significant differences was reduced due to the lower sample size of subjects with BP-II. Female sex was a significant predictor of rapid cycling, cycle acceleration, and increased severity of mood episodes over time after adjusting for age, bipolar disorder subtype, BMI, having any comorbid psychiatric disorder, and current antidepressant use. CONCLUSIONS: Female sex was associated with significantly higher risk of rapid cycling, cycle acceleration, and increased severity of mood episodes over time in a sample of 1,225 patients with bipolar disorders.
OBJECTIVES: To examine the independent effects of sex on the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I disorder (BP-I) or bipolar II disorder (BP-II). METHODS: We analyzed data from the first 1,225 patients enrolled in the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder. Demographic and clinical variables were ascertained using standardized questionnaires; height and weight were assessed to determine body mass index (BMI). Rates of rapid cycling, cycle acceleration, and increased severity of mood episodes over time were compared between women and men overall and within subgroups defined by bipolar disorder subtype (BP-I or BP-II). Multiple logistic regression analysis was used to assess the independent effect of sex on the risk of these indicators of adverse illness course. RESULTS:Women had significantly higher rates of rapid cycling than men. Overall rates of rapid cycling were higher in patients with BP-II than BP-I; and sex differences in the rate of rapid cycling were more pronounced in patients with BP-II than BP-I, although the power to detect statistically significant differences was reduced due to the lower sample size of subjects with BP-II. Female sex was a significant predictor of rapid cycling, cycle acceleration, and increased severity of mood episodes over time after adjusting for age, bipolar disorder subtype, BMI, having any comorbid psychiatric disorder, and current antidepressant use. CONCLUSIONS: Female sex was associated with significantly higher risk of rapid cycling, cycle acceleration, and increased severity of mood episodes over time in a sample of 1,225 patients with bipolar disorders.
Authors: Marin Veldic; Vincent Millischer; John D Port; Ada Man-Choi Ho; Yun-Fang Jia; Jennifer R Geske; Joanna M Biernacka; Lena Backlund; Susan L McElroy; David J Bond; J Carlos Villaescusa; Michelle Skime; Doo-Sup Choi; Catharina Lavebratt; Martin Schalling; Mark A Frye Journal: Transl Psychiatry Date: 2019-05-23 Impact factor: 6.222
Authors: I H Heiberg; B K Jacobsen; L Balteskard; J G Bramness; Ø Naess; E Ystrom; T Reichborn-Kjennerud; C M Hultman; R Nesvåg; A Høye Journal: Acta Psychiatr Scand Date: 2019-03-29 Impact factor: 6.392
Authors: William A Jons; Colin L Colby; Susan L McElroy; Mark A Frye; Joanna M Biernacka; Stacey J Winham Journal: Biol Sex Differ Date: 2019-12-09 Impact factor: 5.027
Authors: Gabriëlla A M Blokland; Jakob Grove; Chia-Yen Chen; Chris Cotsapas; Stuart Tobet; Robert Handa; David St Clair; Todd Lencz; Bryan J Mowry; Sathish Periyasamy; Murray J Cairns; Paul A Tooney; Jing Qin Wu; Brian Kelly; George Kirov; Patrick F Sullivan; Aiden Corvin; Brien P Riley; Tõnu Esko; Lili Milani; Erik G Jönsson; Aarno Palotie; Hannelore Ehrenreich; Martin Begemann; Agnes Steixner-Kumar; Pak C Sham; Nakao Iwata; Daniel R Weinberger; Pablo V Gejman; Alan R Sanders; Joseph D Buxbaum; Dan Rujescu; Ina Giegling; Bettina Konte; Annette M Hartmann; Elvira Bramon; Robin M Murray; Michele T Pato; Jimmy Lee; Ingrid Melle; Espen Molden; Roel A Ophoff; Andrew McQuillin; Nicholas J Bass; Rolf Adolfsson; Anil K Malhotra; Nicholas G Martin; Janice M Fullerton; Philip B Mitchell; Peter R Schofield; Andreas J Forstner; Franziska Degenhardt; Sabrina Schaupp; Ashley L Comes; Manolis Kogevinas; José Guzman-Parra; Andreas Reif; Fabian Streit; Lea Sirignano; Sven Cichon; Maria Grigoroiu-Serbanescu; Joanna Hauser; Jolanta Lissowska; Fermin Mayoral; Bertram Müller-Myhsok; Beata Świątkowska; Thomas G Schulze; Markus M Nöthen; Marcella Rietschel; John Kelsoe; Marion Leboyer; Stéphane Jamain; Bruno Etain; Frank Bellivier; John B Vincent; Martin Alda; Claire O'Donovan; Pablo Cervantes; Joanna M Biernacka; Mark Frye; Susan L McElroy; Laura J Scott; Eli A Stahl; Mikael Landén; Marian L Hamshere; Olav B Smeland; Srdjan Djurovic; Arne E Vaaler; Ole A Andreassen; Bernhard T Baune; Tracy Air; Martin Preisig; Rudolf Uher; Douglas F Levinson; Myrna M Weissman; James B Potash; Jianxin Shi; James A Knowles; Roy H Perlis; Susanne Lucae; Dorret I Boomsma; Brenda W J H Penninx; Jouke-Jan Hottenga; Eco J C de Geus; Gonneke Willemsen; Yuri Milaneschi; Henning Tiemeier; Hans J Grabe; Alexander Teumer; Sandra Van der Auwera; Uwe Völker; Steven P Hamilton; Patrik K E Magnusson; Alexander Viktorin; Divya Mehta; Niamh Mullins; Mark J Adams; Gerome Breen; Andrew M McIntosh; Cathryn M Lewis; David M Hougaard; Merete Nordentoft; Ole Mors; Preben B Mortensen; Thomas Werge; Thomas D Als; Anders D Børglum; Tracey L Petryshen; Jordan W Smoller; Jill M Goldstein Journal: Biol Psychiatry Date: 2021-03-23 Impact factor: 12.810